Bicycle Therapeutics (BCYC) Interest & Investment Income (2018 - 2026)
Bicycle Therapeutics posted quarterly Interest & Investment Income of $4.9 million for Q1 2026, down 42.04% year-on-year from $8.4 million in Q1 2025, and down 17.0% on a QoQ basis from $5.9 million in Q4 2025.
Bicycle Therapeutics (BCYC) has 9 years of Interest & Investment Income data on file, last reported at $4.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 42.04% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $24.9 million (down 32.77% YoY), and the FY2025 full-year result was $28.5 million, down 16.98% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $4.9 million, down from $5.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $10.6 million in Q3 2024 and bottomed at $218000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $5.6 million (2024), against an average of $5.1 million.
- The widest annual swing landed in 2022, when Interest & Investment Income jumped 8195.83%; it then tumbled 42.97% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $2.6 million in 2022, then jumped by 137.82% to $6.3 million in 2023, then soared by 64.17% to $10.3 million in 2024, then plunged by 42.97% to $5.9 million in 2025, then slipped by 17.0% to $4.9 million in 2026.
- The last three Interest & Investment Income figures came in at $4.9 million (Q1 2026), $5.9 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | 4.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.88 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 7.47 Mn |
| Mar 31, 2025 | 8.41 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 10.58 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 6.28 Mn |
| Sep 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | 812,000.00 |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 908,000.00 |
| Mar 31, 2022 | 218,000.00 |
| Dec 31, 2021 | 59,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Dec 31, 2020 | 28,000.00 |
| Sep 30, 2020 | 72,000.00 |
| Jun 30, 2020 | 371,000.00 |
| Mar 31, 2020 | 212,000.00 |
| Dec 31, 2019 | 220,000.00 |
| Sep 30, 2019 | 440,000.00 |
| Jun 30, 2019 | 90,000.00 |
| Mar 31, 2019 | 64,000.00 |
| Dec 31, 2018 | 94,000.00 |
| Sep 30, 2018 | 26,000.00 |
| Jun 30, 2018 | 52,000.00 |